Tag: Europe
-
Institutions Join Global Health Breakthrough Network
Wellcome Leap aims to establish a model for faster design and development of health breakthroughs, beginning with elimination of administrative obstacles.
-
Food Allergy Biotech Raises $40M in New Funds
A biotechnology company designing proteins in food products and therapies for people with food allergies is raising $40 million in its second venture round.
-
Drug Maker Gains Access to Hidden Protein Immunotherapies
Global drug maker Boehringer Ingelheim is gaining access to an immunotherapy technology that targets usually hidden proteins to attack cancer cells.
-
Vaccine Shown Active Against New Covid-19 Variants
A current Covid-19 vaccine is shown in lab tests to produce antibodies that appear to protect against new mutations found in South Africa and the U.K.
-
CureVac, Bayer Partner on Covid-19 Vaccine Supply
Vaccine developer CureVac and global drug maker Bayer are partnering on further development, authorization, and supply of CureVac’s Covid-19 vaccine.
-
Synthetic Biology Company Raises $105M in New Funds
A company developing cellular and genetic therapies for cancer designed like electronic circuits is raising $105 million in its second venture round.
-
Global Vaccine Funds in Covid-19 Relief Bill
The Covid-19 relief bill that the U.S. Congress expects to pass today has more funds for an international group distributing vaccines to low-resource regions.
-
Neuroscience Biotech Acquired in $770M Deal
A three year-old biotechnology company developing treatments for psychiatric and movement disorders is being acquired by global drug maker Novartis.
-
Trial Testing Ultrasound, Chemo for Brain Tumors
A clinical trial is underway assessing an implanted ultrasound device with chemotherapy to treat glioblastoma, an aggressive form of brain cancer.
-
AbbVie Acquires Coronavirus Antibody Therapy
Drug maker AbbVie is licensing a synthetic antibody to treat Covid-19 and SARS coronaviruses that the company began funding in June.